Make earnings with no risk
Automated AI-driven system makes the trades, you earn the money
Join now

Cannabis Stocks Surge as DEA Reviews


If marijuana is classified as Schedule III, it could potentially eliminate the burdensome 280E tax regulations that currently prevent state-legal cannabis companies from claiming customary business cost deductions. This development has brought about an upward trajectory for several key players in the industry.

Curaleaf Holdings Inc. (CURLF) has seen a 5% increase after gaining 4.8% on Wednesday, while Trulieve Cannabis Corp. (TCNNF) experienced a 3.6% rise following a 2.2% increase the previous day. Green Thumb Industries (GTBIF) saw an 0.8% increase after a 3.5% gain in the previous session. Cresco Labs (CRLBF) rose by 7.9%, building on an 8.2% advance from the prior session. Verano Holdings Corp. (VRNOF) experienced a minor dip of 0.3% after a notable 8.7% increase on Wednesday. Meanwhile, TerrAscend Corp. (TSNDF) climbed by 1.1% after a substantial 10.6% gain in the previous session. The Advisor Shares Pure U.S. Cannabis ETF (MSOS) recorded a 3% increase in addition to its 5.6% surge on Wednesday.

Under current federal law, Schedule I drugs are defined as having no medical use and include substances such as heroin and LSD. In contrast, Schedule III classification permits regulated medical use of controlled substances.

U.S. Ethanol Production Sees Slight Decline

Previous article

Determining When It’s Time to Cut Your Losses in Investments

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in News